Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Polycythemia Vera × Interferons × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 5 Melanoma 4 Lymphoma, Follicular 3 Lymphoma 3 Sarcoma 2 Lymphoma, Non-Hodgkin 2 Carcinoma, Renal Cell 2 Zollinger-Ellison Syndrome 1 Virus Diseases 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Polycythemia Vera 1 Multiple Myeloma 1 Meningeal Carcinomatosis 1 Lymphoproliferative Disorders 1 Lymphomatoid Granulomatosis 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia 1 Kidney Neoplasms 1 Influenza, Human 1 Gastrointestinal Cancer Metastatic 1 Epstein-Barr Virus Infections 1 Colonic Neoplasms 1 Carcinoma, Transitional Cell 1 Carcinoma, Hepatocellular 1 Carcinoma in Situ 1 Breast Neoplasms 1 Brain Neoplasms 1 Adenoviridae Infections 1

Interventions

fludarabine phosphate 23 ruxolitinib 21 Peripheral Blood Stem Cell Transplantation 20 Cyclophosphamide 20 Busulfan 14 Whole-Body Irradiation 12 Tacrolimus 12 Mycophenolic Acid 12 Methotrexate 10 Cyclosporine 10 Antilymphocyte Serum 9 Filgrastim 7 Decitabine 7 Aspirin 7 Melphalan 6 Etoposide 6 Cytarabine 6 givinostat hydrochloride 5 givinostat 5 fludarabine 5 Radiotherapy 5 Hydroxyurea 5 11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 5 peginterferon alfa-2a 4 Stem Cell Transplantation 4 Phlebotomy 4 Methylprednisolone 4 Imatinib Mesylate 4 Biopsy 4 bomedemstat 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04116502 2024-11-18

MITHRIDATE

University of Birmingham

Phase 3 Recruiting

Polycythemia Vera

Data powered by HemOnc (CC BY 4.0) Colophon ⚡